Ralph Schimmer

Ralph has been Chief Medical Officer and Head Global Medical & Scientific Affairs for Centralised and Point of Care Solutions (CPS) within the Roche Diagnostics division since May 2014.

Ralph began his career at Roche in 2000 as a Medical Director and Clinical Scientist within Roche Pharma Development in Basel, Switzerland. Before joining Roche Diagnostics, Ralph served as Global Head Drug Safety Science – Cardiometabolism within the Roche Pharma Development organization.

Since 2012 Ralph has also been the Roche coordinator of the Innovative Medicines Initiative’s (IMI) project Eu2P, a public-private partnership with a consortium of 7 European universities, 15 pharmaceutical companies and the European and French Medicines Agencies. 

Ralph received a Medical Degree (M.D.) and Doctor of Medicine (Dr. Med.) from the University of Munich Medical School, Germany, and a Master of Business and Administration (M.B.A.) from the William E. Simon Graduate School of Business Administration at the University of Rochester, New York, USA. He is a board certified physician and surgeon and lecturer at the University of Zurich Medical School.